Background: Use of intra-articular antibiotics for the treatment of arthroplasty infections has gained some interest over the last few years.
Objective: Some data exists on its use with bacterial arthroplasty infections.
Method: We used intra-articular amphotericin B in an attempt to cure these joint infections and perform a one stage revision.
Results: Two patients were treated with intra-articular amphotericin B for 6 weeks followed by suppressive fluconazole for 4 months. Intra-articular joint fluid was cultured during this process for re-growth of fungus.
Conclusion: Both patients were treated successfully with the method with follow up showing no evidence of recurrence. IA administration of amphotericin B may be an alternative treatment in these patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2174/1871526516666161026125606 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The heavy burden and treatment challenges of fungal periprosthetic joint infection: a systematic review of 489 joints.
BMC Musculoskelet Disord
August 2024
Department of Orthopedics, The Fourth Medical Center of Chinese People's Liberation Army General Hospital, No.51 Fucheng Road, Haidian District, Beijing, China.
Article Synopsis
- Fungal periprosthetic joint infection (FPJI) is a rare but serious problem for patients who have joint surgeries, and there is no best treatment agreed upon yet.
- Researchers looked at 24 studies and gathered info on 489 joints, focusing on the type of fungi, infections with bacteria, and different treatment methods.
- They found that the most common fungus was Candida albicans, and the two-stage surgery approach worked best, with lower infection rates compared to other methods.
Pharmacokinetics of intraarticular liposomal amphotericin B in goats (Capra aegagrus hircus).
J Vet Pharmacol Ther
July 2024
K. L. Maddy Equine Analytical Pharmacology Laboratory, School of Veterinary Medicine, University of California-Davis, Davis, California, USA.
Lameness is a significant welfare concern in goats. Amphotericin B is used via intraarticular (IA) administration in models to study experimentally induced lameness in large animals. The main objective of this study was to estimate plasma pharmacokinetic (PK) parameters for amphotericin B in goats after a single IA administration.
View Article and Find Full Text PDFOptimal lameness induction model development using amphotericin B in meat goats.
Transl Anim Sci
September 2023
Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, 1800 Denison Ave., Manhattan KS 66502, USA.
Lameness continues to be a critical health and welfare concern associated with goat production. Amphotericin B (amp B) is an antimicrobial successful in inducing transient lameness for research purposes previously in livestock animals. The objectives of this study were to (1) identify which of three varying doses of amp B would be most effective in inducing lameness in meat type goats and (2) develop a facial grimace scale for goats.
View Article and Find Full Text PDFVoriconazole Admixed with PMMA-Impact on Mechanical Properties and Efficacy.
Antibiotics (Basel)
May 2023
University Hospital for Orthopaedics and Traumatology, Medical University of Graz, 8036 Graz, Austria.
Background: There are currently no recommendations to direct the optimal diagnosis and treatment of fungal osteoarticular infections, including prosthetic joint infections and osteomyelitis. Active agents (fluconazole; amphotericin B) are regularly applied per os or intravenously. Other drugs such as voriconazole are used less frequently, especially locally.
View Article and Find Full Text PDFRandomized controlled trial comparison of analgesic drugs for control of pain associated with induced lameness in lactating dairy cattle.
J Dairy Sci
February 2021
Department of Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames 50011. Electronic address:
Both the economic loss and welfare implications of lameness affect the dairy industry. Currently no analgesic drugs are approved to alleviate lameness-associated pain in lactating dairy cattle in the United States. In this randomized controlled trial, 48 lactating Holsteins were enrolled to evaluate the effect of oral meloxicam and i.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!